BIIB
Biogen Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$220.35
−1.85%Margins
Gross margin
67.7%
EBITDA margin
16.8%
EBIT margin
12.8%
Net margin
8.4%
FCF margin
29.8%
4.4%
Return on equity
2.6%
Return on assets
4.7%
Return on invested capital
0.32x
Asset turnover
$2.9B
Cash from operations
$8.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026